Oncoinvent ASA (ONCIN) — Cash Flow-to-Debt Ratio
Latest as of June 2025:
-3.74x
Oncoinvent ASA (ONCIN) has a Cash Flow-to-Debt Ratio of -3.74x as of June 2025, meaning its operating cash flow of Nkr-73.90 Million could theoretically repay -4% of its total liabilities (Nkr19.75 Million) in one year. See financial agility of Oncoinvent ASA to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-3.74x
Operating CF / Total Liabilities
Operating Cash Flow
Nkr-73.90 Million
NOK
Total Liabilities
Nkr19.75 Million
NOK
Data as of
Jun 2025
Most recent filing
Oncoinvent ASA Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Oncoinvent ASA across 5 annual periods. For the full cash flow conversion analysis, see Oncoinvent ASA (ONCIN) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Oncoinvent ASA (2021–2025)
Year-by-year debt coverage analysis for Oncoinvent ASA.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.24x | Nkr-131.19 Million | Nkr58.63 Million | ▲ +8.5% |
| 2024 | -2.44x | Nkr-153.24 Million | Nkr62.68 Million | ▲ +17.1% |
| 2023 | -2.95x | Nkr-138.11 Million | Nkr46.86 Million | ▲ +20.0% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr65.81 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.